LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 39 filers reported holding LUMOS PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,248 | +56.0% | 7,652 | +56.0% | 0.00% | – |
| Q2 2023 | $16,187 | +7.9% | 4,906 | +8.3% | 0.00% | – |
| Q1 2023 | $14,995 | +76.1% | 4,531 | +80.2% | 0.00% | – |
| Q4 2022 | $8,513 | -34.5% | 2,514 | +69.5% | 0.00% | – |
| Q3 2022 | $13,000 | -40.9% | 1,483 | -46.7% | 0.00% | – |
| Q2 2022 | $22,000 | -31.2% | 2,782 | -16.9% | 0.00% | – |
| Q1 2022 | $32,000 | +60.0% | 3,348 | +10.9% | 0.00% | – |
| Q4 2021 | $20,000 | +25.0% | 3,018 | +82.0% | 0.00% | – |
| Q3 2021 | $16,000 | -33.3% | 1,658 | -30.8% | 0.00% | – |
| Q2 2021 | $24,000 | +71.4% | 2,396 | +98.0% | 0.00% | – |
| Q1 2021 | $14,000 | -66.7% | 1,210 | 0.0% | 0.00% | – |
| Q4 2020 | $42,000 | -2.3% | 1,210 | -61.3% | 0.00% | – |
| Q3 2020 | $43,000 | -17.3% | 3,130 | -0.2% | 0.00% | – |
| Q2 2020 | $52,000 | +100.0% | 3,137 | +1.1% | 0.00% | – |
| Q1 2020 | $26,000 | – | 3,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 407,192 | $5,627,000 | 1.23% |
| Opaleye Management Inc. | 240,892 | $3,329,000 | 0.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 936,291 | $12,940,000 | 0.32% |
| NEA Management Company, LLC | 526,663 | $7,278,000 | 0.31% |
| Investors Financial Group, LLC | 21,766 | $301,000 | 0.22% |
| Wealth Advisors of Iowa, LLC | 11,760 | $163,000 | 0.11% |
| Blackstone Inc. | 468,145 | $6,470,000 | 0.02% |
| Jefferies Group LLC | 120,651 | $1,667,000 | 0.02% |
| Texas Yale Capital Corp. | 16,000 | $221,000 | 0.02% |
| Prospera Financial Services Inc | 1,088 | $15,000 | 0.01% |